Profil
John Apeler Keller is currently a Director at ViiV Healthcare Ltd. and a Director at Shionogi Ltd. He was previously the President, CEO & Director at Shionogi, Inc. from 2010 to 2012.
Prior to that, he was a Director at diaDexus, Inc. from 2003 to 2010 and the Chief Business Officer & Executive Vice President at Incyte Corp.
from 2003 to 2008.
He was also a Partner at GSK Equity Investments Ltd. from 2008 to 2010.
Keller held Vice President-Business Development positions at GSK Plc and Smithkline Beckman Corp.
Keller holds a doctorate from Rutgers State University of New Jersey and an undergraduate degree from The Johns Hopkins University.
Aktive Positionen von John Apeler Keller
| Unternehmen | Position | Beginn |
|---|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Direktor/Vorstandsmitglied | 31.10.2012 |
Shionogi Ltd.
Shionogi Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Direktor/Vorstandsmitglied | 14.05.2014 |
Ehemalige bekannte Positionen von John Apeler Keller
| Unternehmen | Position | Ende |
|---|---|---|
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets diagnostic products | Direktor/Vorstandsmitglied | 01.11.2010 |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 30.03.2010 |
| INCYTE CORPORATION | Corporate Officer/Principal | 12.09.2008 |
| GSK PLC | Corporate Officer/Principal | - |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Vorstandsvorsitzender | - |
Ausbildung von John Apeler Keller
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets diagnostic products | Health Technology |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Smithkline Beckman Corp
Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
Shionogi Ltd.
Shionogi Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
















